Serum Concentrations of Lidocaine During Bariatric Surgery.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 30399021.
- Also identified by DOI 10.1213/ANE.0000000000003905.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lidocaine has been shown to be clinically beneficial during bariatric surgery. However, information about lidocaine serum concentrations in this setting is scarce. This prospective clinical trial included 42 obese patients undergoing laparoscopic bariatric surgery. They received lidocaine based on adjusted body weight. Administration began with a 1.5 mg·kg bolus of intravenous lidocaine followed by a continuous infusion of 2 mg·kg·hour. After skin closure, administration was decreased to 1 mg·kg·hour until discharge from the recovery room. No serum concentrations of lidocaine were outside the usual accepted range (1.5-5 µg·mL).
Medical subject headings
- Anesthetics, Local
- Gastrectomy
- Gastric Bypass
- Laparoscopy
- Lidocaine
- Obesity